Mayne Pharma Group Ltd

HG6

Company Profile

  • Business description

    Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women’s Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women’s Health segment distributes branded women’s health products in the U.S. International’s segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

  • Contact

    1538 Main North Road
    Salisbury South
    SalisburySA5106
    AUS

    T: +61 882092666

    https://www.maynepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    30 June 2026

    Employees

    160

Stocks News & Analysis

stocks

This might be the best core stock bargain in the US market today

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.
stocks

Data center demand drives strong earnings outlook for SGM

Sims guides huge earnings upgrade as data center metals demand spikes.
stocks

Chart of the Week: AI proving a threat to company moats

The latest insights on AI from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,628.3034.80-0.40%
CAC 407,665.62142.25-1.82%
DAX 4022,380.19459.37-2.01%
Dow JONES (US)45,577.47443.96-0.96%
FTSE 1009,918.33145.17-1.44%
HKSE25,277.32223.26-0.88%
NASDAQ21,647.61443.08-2.01%
Nikkei 22553,372.531,866.87-3.38%
NZX 50 Index12,921.3968.60-0.53%
S&P 5006,506.48100.01-1.51%
S&P/ASX 2008,428.4043.90-0.52%
SSE Composite Index3,957.0549.50-1.24%

Market Movers